CIS Insulin Market

Future Market Insights

Key Insight

The cis insulin market is projected to grow from USD 506.2 million in 2025 to USD 660.7 million by 2035, at a CAGR of 2.7%. Rapid Acting CIS Insulin will dominate with a 28.4% market share, while cis insulin for treating type ii diabetes will lead the application segment with a 62.7% share.

August 25, 2025

Anurag Sharma

297 Pages

Cite this Report

CIS Insulin Market

https://www.futuremarketinsights.com/reports/cis-insulin-market

License

Buy Now

Summary ToC Companies

Key Players

Dongbao Enterprise Group Co. Ltd
Oramed Pharmaceuticals Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

CIS Insulin Market

Key Players

Similar Industry Reports